News
The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...
Days after JCR Pharmaceuticals signed a deal with AstraZeneca’s rare disease unit, the Japanese biopharma has secured a ...
The Mirror's former editor Alison Phillips has spoken to ITV's Lorraine Kelly about her friend Fiona Phillips, giving an update on her experience with Alzheimer's ...
Robert Johnson was last seen on Monday night at an apartment complex on Trinity Place, and police are hoping someone knows ...
Fiona Phillips ’ husband Martin Frizell has opened up about the painful moment the TV presenter failed to recognise their ...
A groundbreaking study reveals that misfolded "stealth" proteins—not just plaques—may play a major role in cognitive decline.
Fiona Phillips was diagnosed with Alzheimer's disease in 2022 and tragically, she was almost sure she would get the condition after both of her parents suffered from it.
Former GMTV presenter Fiona Phillips announced in 2023 that she had been diagnosed with Alzheimer's - and her parents both ...
Connecticut joins more than 20 states mandating insurance coverage cover biomarker tests, said Christy Kovel, director of ...
Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results